RECOMBINATE 500 IU

Země: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Aktivní složka:

COAGULATION FACTOR VIII RECOMBINANT 500 IU/VIAL

Dostupné s:

TEVA MEDICAL MARKETING LTD.

ATC kód:

B02BD05

Léková forma:

POWDER FOR SOLUTION FOR INJECTION

Podání:

I.V

Výrobce:

BAXTER S.A., BELGIUM

Terapeutické skupiny:

COAGULATION FACTOR VII

Terapeutické indikace:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Datum autorizace:

2010-07-01